FIELD: pharmaceutics.
SUBSTANCE: invention relates to piperazine compounds of the formula (I).
EFFECT: new compounds of the formula (I) are obtained that can be used as MAGL modulators.
6 cl
Title | Year | Author | Number |
---|---|---|---|
SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS | 2018 |
|
RU2726631C1 |
HETEROCYCLIC IMMUNOMODULATORS AS INHIBITOR OF IMMUNE RESPONSE CHECKPOINTS PDL1 | 2020 |
|
RU2824127C2 |
11,13-MODIFIED SAXITOXINS FOR PAIN TREATMENT | 2018 |
|
RU2778455C2 |
ROUTES OF APPLICATION OF PHOSPHODIESTERASE INHIBITORS | 2020 |
|
RU2795503C2 |
MACROCYCLIC PHENYLCARBAMATES INHIBITING HCV | 2008 |
|
RU2490261C2 |
CRYSTALLINE FORMS OF MAGL INHIBITOR | 2017 |
|
RU2799564C2 |
ROR-GAMMA MODULATORS | 2017 |
|
RU2753490C2 |
Authors
Dates
2021-09-03—Published
2017-11-15—Filed